High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiag172 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Astrid Marchal und 20 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (Inserm) U1163, Necker …. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Autoantibodies, COVID-19, Interferon Type I. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, Rockefeller University, Meyer Foundation.
Abstract (Originalsprache)
Autoantibodies neutralizing type I interferon (AAN-I-IFNs) underlie life-threatening COVID-19. In hospitalized COVID-19 patients of the DisCoVeRy trial (NCT-04315948), AAN-I-IFNs were associated with higher nasopharyngeal viral load at inclusion (P = 1.4 × 10−3) and delayed viral clearance (P = .013). Blood AAN-I-IFNs, high viral load and delayed clearance were also independent risk factors for critical COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (Inserm) U1163, Necker Hospital for Sick Children, Paris, France.
- Imagine Institute, Paris Cité University, Paris, France.
- AP-HP, Département des Maladies Infectieuses et Tropicales, Hôpital Saint-Louis, Lariboisière, Paris, France.
- Faculté de Médecine, Sorbonne Université, Paris, France.
- Université Paris Cité et Université Sorbonne Paris Nord, Inserm, IAME, Paris, France.
- St.Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA.
ORCID-Profile: Astrid Marchal, Thibault Kerdiles, Aglaé Perrin, Adrian Gervais, Paul Bastard, Lucy Bizien, Guillaume Lingas, Clément R Massonnaud, Maude Bouscambert-Duchamp, Alexandre Gaymard, Nathan Peiffer-Smadja, Jérémie Guedj, Anne Puel, Maya Hites, Florence Ader, Julie Bertrand, Aurélie Cobat
Förderung
- NIH HHS
- Rockefeller University
- Meyer Foundation
- European Commission
- ANR-RHU COVIFERON Program
- NIAID NIH HHS
- European Regional Development Fund
- ANR GENVIR
Zitieren
APA
Marchal, A., Kerdiles, T., Perrin, A., Gervais, A., Bastard, P., Bizien, L., Lingas, G., Massonnaud, C. R., Bouscambert-Duchamp, M., Gaymard, A., Peiffer-Smadja, N., Mentre, F., Guedj, J., Abel, L., Casanova, J. L., Puel, A., Hites, M., Ader, F., Bertrand, J., …, & DisCoVeRy Study Group (2026). High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag172
Vancouver
Marchal A, Kerdiles T, Perrin A, Gervais A, Bastard P, Bizien L, et al. High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag172
BibTeX
@article{Marchal2026,
author = {Marchal, Astrid and Kerdiles, Thibault and Perrin, Aglaé and Gervais, Adrian and Bastard, Paul and Bizien, Lucy and Lingas, Guillaume and Massonnaud, Clément R and Bouscambert-Duchamp, Maude and Gaymard, Alexandre and Peiffer-Smadja, Nathan and Mentre, France and Guedj, Jérémie and Abel, Laurent and Casanova, Jean-Laurent and Puel, Anne and Hites, Maya and Ader, Florence and Bertrand, Julie and Cobat, Aurélie and DisCoVeRy Study Group, DisCoVeRy Study Group},
title = {High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiag172}
}
EUVIMED